Discover sepsis muscle weakness and cell energy

What is sepsis muscle weakness?

Sepsis is a dangerous condition where the body has an extreme response to infection. Even when someone survives, recovery can be long and frustrating. Many people leave the hospital feeling very weak, especially after time in intensive care. Doctors call this ICU-acquired weakness, and it can make simple tasks like standing, walking, or climbing stairs much harder.

A new mouse study from researchers at Ehime University, published in Scientific Reports as beta-nicotinamide mononucleotide preserves muscle strength in septic male mice, looked closely at why this weakness can last. The team found something important: muscles may look like they have recovered in size, but they can still be weak because their tiny energy factories are not working well.

Why muscle strength can stay low after sepsis

This idea is not completely new. Earlier work in eLife showed that chronic muscle weakness and mitochondrial dysfunction after sepsis can continue even without lasting muscle shrinkage. In simple terms, the muscle may be there, but it may not have enough usable energy.

That matters in real life. A person recovering from sepsis might regain body weight and still feel tired, shaky, or unable to do everyday activities. This study helps explain why. It suggests that measuring recovery by body weight alone may miss a big part of the problem.

How mitochondria affect muscle energy after sepsis

Inside muscle cells are mitochondria. You can think of them as tiny batteries or power plants. They help turn food into energy. If mitochondria are damaged, muscles cannot do their job well.

In the new study, mice with sepsis had lower grip strength even 14 days later. By that point, body weight and muscle mass had mostly recovered, but muscle function had not. When the researchers examined the muscle tissue, they found ongoing mitochondrial abnormalities. They also saw changes in genes linked to mitochondrial dysfunction.

This is a useful reminder for patients, families, and clinicians: feeling weak after severe illness is not always just about lost muscle size. It can also be about poor muscle energy production. For more plain-language context on how genes can shape physical decline with age, Slothwise has a helpful explainer on how genetics shapes frailty as we age.

What SIRT3 does in muscle cells

The researchers focused on a protein called SIRT3. This protein helps mitochondria work properly by controlling how other mitochondrial proteins are chemically modified. SIRT3 is part of a larger NAD-related system that helps cells manage energy. The basic biology behind this system was established in classic work on NAD dependent cell energy control and mitochondrial stress in sepsis-related muscle weakness.

In the new study, Sirt3 levels were lower in septic muscle. The team also found more acetylated mitochondrial proteins, which is a sign that this control system was not working normally. Some of the affected proteins were linked to complex I, an important part of the cell machinery that makes energy.

To test this further, the scientists reduced Sirt3 in cultured muscle cells called C2C12 myotubes. When they did that, the cells had worse mitochondrial respiration, meaning they were less able to make energy efficiently.

Can NMN help sepsis muscle weakness?

The most interesting part of the study was the test of beta-NMN, short for beta-nicotinamide mononucleotide. NMN is a molecule the body can use to make NAD+, which supports cell energy systems.

When the researchers gave beta-NMN during the acute phase of sepsis in mice, muscle strength was better preserved. The treatment also helped maintain healthier mitochondrial shape. Importantly, it did not increase muscle mass. That tells us the benefit was likely about better muscle quality and energy function, not bigger muscles.

This fits with the idea that nutrition in critical illness is not only about calories. It may also be about supporting how cells make energy. That is one reason researchers are paying more attention to targeted nutrition strategies after severe illness.

What this means for recovery after intensive care

This does not mean people should rush to buy NMN supplements. The study was done in male mice, not in humans, and mouse results often do not translate perfectly to patient care. We also do not yet know the best dose, timing, safety, or which patients might benefit most.

Still, the findings are encouraging. They suggest that post-sepsis weakness may be partly treatable if doctors can protect mitochondria early. In the future, this kind of work could help shape smarter ICU recovery plans that combine nutrition, physical therapy, and possibly metabolism-focused treatments. That is also where tools like Slothwise and health AI may become useful, helping people track recovery patterns and understand complex science in a more personal way.

If you are curious about mitochondria more broadly, Slothwise also offers extra background on how mitochondria size and shape change with energy balance. It is not about sepsis, but it does help explain why mitochondria are so central to health.

Why this sepsis research matters now

Sepsis survivors often say the hardest part starts after they leave the hospital. This study adds an important piece to that puzzle. It shows that muscle weakness may linger because the cell engines inside muscle are still struggling, even when the outside looks better.

That is a hopeful message as much as a caution. If scientists can understand the energy problem, they may be able to design better ways to help people regain strength. For now, the study supports a careful, evidence-based view: recovery after sepsis is about more than body weight, and healthy mitochondria may be one of the keys.